BJU international

publication venue for

External validation of an artificial intelligence model for Gleason grading of prostate cancer on prostatectomy specimens. 2024
Optimal pathological response after neoadjuvant chemotherapy for muscle-invasive bladder cancer: results from a global, multicentre collaboration.. 128. 2021
Longitudinal follow-up and performance validation of an mRNA-based urine test (Xpert^® Bladder Cancer Monitor) for surveillance in patients with non-muscle-invasive bladder cancer. 2021
A risk calculator predicting recurrence in lymph node metastatic penile cancer.. 126. 2020
A comparative propensity score-matched analysis of perioperative outcomes of intracorporeal vs extracorporeal urinary diversion after robot-assisted radical cystectomy: results from the International Robotic Cystectomy Consortium.. 126. 2020
Optimising the selection of candidates for neoadjuvant chemotherapy amongst patients with node-positive penile squamous cell carcinoma.. 125. 2020
Extraperitoneal single-port robot-assisted radical prostatectomy: initial experience and description of technique.. 125. 2019
Differences in trends in the use of robot-assisted and open radical cystectomy and changes over time in peri-operative outcomes among selected centres in North America and Europe: an international multicentre collaboration. 2019
Step-by-step technique for single-port robot-assisted radical cystectomy and pelvic lymph nodes dissection using the da Vinci^® SP™ surgical system.. 124. 2019
Robot-assisted surgery for benign distal ureteral strictures: step-by-step technique using the SP^® surgical system.. 123. 2019
The duration of infertility affects semen parameters in primary infertile men: results of a single-centre, cross-sectional study.. 123. 2018
Achieving tumour control when suspecting sinus fat involvement during robot-assisted partial nephrectomy: step-by-step.. 123. 2018
Undiagnosed prediabetes is highly prevalent in primary infertile men - results from a cross-sectional study.. 123. 2018
Safety and efficacy of nivolumab for metastatic renal cell carcinoma: real-world results from an expanded access programme.. 123. 2018
Robot-assisted transvesical partial prostatectomy using a purpose-built single-port robotic system.. 122. 2018
Impact of bladder cancer on health-related quality of life.. 121. 2017
Prostate size, nocturia and the digital rectal examination: a cohort study of 30 500 men.. 119. 2016
Robot-assisted partial cystectomy: perioperative outcomes and early oncological efficacy.. 119. 2016
Magnetic resonance microscopy may enable distinction between normal histomorphological features and prostate cancer in the resected prostate gland.. 119. 2016
Performance of robotic simulated skills tasks is positively associated with clinical robotic surgical performance.. 118. 2016
The safety of robot-assisted cystectomy in patients with previous history of pelvic irradiation.. 118. 2016
Risk of prostate cancer-specific death in men with baseline metabolic aberrations treated with androgen deprivation therapy for biochemical recurrence.. 118. 2016
A survey of patient expectations regarding sexual function following radical prostatectomy.. 118. 2016
Multiphoton microscopy for rapid histopathological evaluation of kidney tumours.. 118. 2015
The impact of re-transurethral resection on clinical outcomes in a large multicentre cohort of patients with T1 high-grade/Grade 3 bladder cancer treated with bacille Calmette-Guérin.. 118. 2015
Variation in serum prostate-specific antigen levels in men with prostate cancer managed with active surveillance.. 118. 2015
Prognostic value of Caveolin-1 in patients treated with radical prostatectomy: a multicentric validation study.. 118. 2015
Association between number of prostate biopsies and patient-reported functional outcomes after radical prostatectomy: implications for active surveillance protocols.. 117. 2015
Patterns of surveillance imaging after nephrectomy in the Medicare population.. 117. 2015
Real-time in vivo periprostatic nerve tracking using multiphoton microscopy in a rat survival surgery model: a promising pre-clinical study for enhanced nerve-sparing surgery.. 116. 2015
Is continent cutaneous urinary diversion a suitable alternative to orthotopic bladder substitute and ileal conduit after cystectomy?. 116. 2015
Preoperative predictive model of recovery of urinary continence after radical prostatectomy.. 116. 2015
Inhibition of urothelial P2X3 receptors prevents desensitization of purinergic detrusor contractions in the rat bladder.. 116. 2015
The effect of hypogonadism and testosterone-enhancing therapy on alkaline phosphatase and bone mineral density.. 115. 2015
Enzalutamide in European and North American men participating in the AFFIRM trial.. 115. 2014
Preoperative predictors of renal function decline after radical nephroureterectomy for upper tract urothelial carcinoma.. 114. 2014
Impact of smoking status and cumulative exposure on intravesical recurrence of upper tract urothelial carcinoma after radical nephroureterectomy.. 114. 2014
Erectile dysfunction in men treated for testicular cancer.. 113. 2014
Predictors of survival in patients with disease recurrence after radical nephroureterectomy.. 113. 2014
Preoperative serum albumin is associated with mortality and complications after radical cystectomy.. 113. 2014
Efficacy of robot-assisted radical cystectomy (RARC) in advanced bladder cancer: results from the International Radical Cystectomy Consortium (IRCC).. 114. 2014
A nomogram including baseline prognostic factors to estimate the activity of second-line therapy for advanced urothelial carcinoma.. 113. 2014
Microsurgical denervation of rat spermatic cord: safety and efficacy data.. 113. 2014
Prognosis of patients with pelvic lymph node (LN) metastasis after radical prostatectomy: value of extranodal extension and size of the largest LN metastasis.. 114. 2014
Impact of peri-operative blood transfusion on the outcomes of patients undergoing radical cystectomy for urothelial carcinoma of the bladder.. 113. 2014
Reflex fluorescence in situ hybridization assay for suspicious urinary cytology in patients with bladder cancer with negative surveillance cystoscopy.. 114. 2014
MRI-safe robot for targeted transrectal prostate biopsy: animal experiments.. 113. 2013
Association of diabetes mellitus and metformin use with oncological outcomes of patients with non-muscle-invasive bladder cancer.. 112. 2013
Trends and inequalities in the surgical management of ureteric calculi in the USA.. 113. 2013
Effect of statin use on outcomes of non-muscle-invasive bladder cancer.. 112. 2013
Cost-effectiveness analysis of tension-free vaginal tape vs burch colposuspension for female stress urinary incontinence in the USA.. 112. 2013
Sildenafil citrate improves erectile function after castration in a rat model.. 113. 2013
Phase II study of everolimus in metastatic urothelial cancer.. 112. 2013
Neutrophil gelatinase-associated lipocalin (NGAL) levels in response to unilateral renal ischaemia in a novel pilot two-kidney porcine model.. 112. 2013
Comparison of laparoendoscopic single site (LESS) and conventional laparoscopic donor nephrectomy at a single institution.. 112. 2013
Comparative assessment of three standardized robotic surgery training methods.. 112. 2013
Gender-specific effect of smoking on upper tract urothelial carcinoma outcomes.. 112. 2013
Impact of renal function on eligibility for chemotherapy and survival in patients who have undergone radical nephro-ureterectomy.. 112. 2013
Impact of surgeon and volume on extended lymphadenectomy at the time of robot-assisted radical cystectomy: results from the International Robotic Cystectomy Consortium (IRCC).. 111. 2013
Pathological response to neoadjuvant chemotherapy for muscle-invasive micropapillary bladder cancer.. 111. 2013
A case-mix-adjusted comparison of early oncological outcomes of open and robotic prostatectomy performed by experienced high volume surgeons.. 111. 2013
Intravesical bacille Calmette-Guérin (BCG) in immunologically compromised patients with bladder cancer.. 111. 2013
Perioperative outcomes of off-clamp vs complete hilar control laparoscopic partial nephrectomy.. 111. 2012
Cost-effective treatment of low-risk carcinoma not invading bladder muscle.. 111. 2012
Predictors of cancer-specific mortality after disease recurrence following radical cystectomy.. 111. 2012
Randomized phase II study of danusertib in patients with metastatic castration-resistant prostate cancer after docetaxel failure.. 111. 2012
Outcomes and prognostic factors in patients with a single lymph node metastasis at time of radical cystectomy.. 111. 2012
Accurate preoperative prediction of non-organ-confined bladder urothelial carcinoma at cystectomy.. 111. 2012
Obesity is associated with worse oncological outcomes in patients treated with radical cystectomy.. 111. 2012
Impact of smoking status at diagnosis on disease recurrence and death in upper tract urothelial carcinoma.. 111. 2012
Systematic classification and prediction of complications after nephrectomy in patients with metastatic renal cell carcinoma (RCC).. 110. 2012
Modulation of bladder afferent signals in normal and spinal cord-injured rats by purinergic P2X3 and P2X2/3 receptors.. 110. 2012
Impact of age on clinicopathological outcomes and recurrence-free survival after the surgical management of nonseminomatous germ cell tumour.. 110. 2012
International validation of the prognostic value of subclassification for AJCC stage pT3 upper tract urothelial carcinoma of the renal pelvis.. 110. 2012
Central obesity as measured by waist circumference is predictive of severity of lower urinary tract symptoms.. 110. 2012
Phase II escalation study of sorafenib in patients with metastatic renal cell carcinoma who have been previously treated with anti-angiogenic treatment.. 109. 2012
Perception of cancer and inconsistency in medical information are associated with decisional conflict: a pilot study of men with prostate cancer who undergo active surveillance.. 110. 2011
Evidence of bladder oversensitivity in the absence of an infection in premenopausal women with a history of recurrent urinary tract infections.. 110. 2011
Locally advanced prostate cancer: a population-based study of treatment patterns.. 109. 2011
Prognostic value of insulin-like growth factor II mRNA binding protein 3 in patients treated with radical prostatectomy.. 110. 2011
Transatlantic Consensus Group on active surveillance and focal therapy for prostate cancer.. 109. 2011
Nodal counts during pelvic lymph node dissection for prostate cancer: an objective indicator of quality under the influence of very subjective factors.. 109. 2011
Preoperative nomograms incorporating magnetic resonance imaging and spectroscopy for prediction of insignificant prostate cancer.. 109. 2011
Symptom profile variability of interstitial cystitis/painful bladder syndrome by age.. 109. 2011
Decision curve analysis assessing the clinical benefit of NMP22 in the detection of bladder cancer: secondary analysis of a prospective trial.. 109. 2011
Germline BRCA mutation does not prevent response to taxane-based therapy for the treatment of castration-resistant prostate cancer.. 109. 2011
Evaluating the utility of a preoperative nomogram for predicting 90-day mortality following radical cystectomy for bladder cancer.. 109. 2011
Combining imaging and ureteroscopy variables in a preoperative multivariable model for prediction of muscle-invasive and non-organ confined disease in patients with upper tract urothelial carcinoma.. 109. 2011
The economics of robotic cystectomy: cost comparison of open versus robotic cystectomy.. 108. 2011
Current and emerging treatment modalities for metastatic castration-resistant prostate cancer.. 107 Suppl 2. 2011
Fifteen-year trend in the use of male reproductive surgery: analysis of the healthcare cost and utilization project data.. 107. 2011
Do pelvic dimensions and prostate location contribute to the risk of experiencing complications after radical prostatectomy?. 108. 2011
Multiphoton microscopy for structure identification in human prostate and periprostatic tissue: implications in prostate cancer surgery.. 108. 2011
Varicocele as a risk factor for androgen deficiency and effect of repair.. 108. 2011
Regional lymph node status in patients with bladder cancer found to be pathological stage T0 at radical cystectomy following systemic chemotherapy.. 108. 2011
Urinary cytology has a poor performance for predicting invasive or high-grade upper-tract urothelial carcinoma.. 108. 2011
Extending the indications and anatomical limits of pelvic lymph node dissection for prostate cancer: improved staging or increased morbidity?. 108. 2010
Pilot study of salvage laparoscopic prostatectomy for the treatment of recurrent prostate cancer.. 108. 2010
A phase II study of the efficacy and safety of AMG 102 in patients with metastatic renal cell carcinoma.. 108. 2010
Prognostic risk stratification of pathological stage T2N0 bladder cancer after radical cystectomy.. 108. 2010
Are histopathological features of prostate cancer lesions associated with identification of extracapsular extension on magnetic resonance imaging?. 106. 2010
Bladder cancer in cystoscopically normal-appearing mucosa: a case of mistaken identity?. 106. 2010
Location and number of positive surgical margins as prognostic factors of biochemical recurrence after salvage radiation therapy after radical prostatectomy.. 106. 2010
Partial nephrectomy for selected renal cortical tumours of ≥ 7 cm.. 106. 2010
Variability of treatment selection among surgeons for patients with cT1 urothelial carcinoma.. 106. 2010
Early oncological outcomes for bladder urothelial carcinoma patients treated with robotic-assisted radical cystectomy.. 107. 2010
Radical nephrectomy with vena caval thrombectomy: a contemporary experience.. 107. 2010
The depth of the prostatic apex is an independent predictor of positive apical margins at radical prostatectomy.. 106. 2010
Novel ZEB1 expression in bladder tumorigenesis.. 107. 2010
Reduced bladder tumour recurrence rate associated with narrow-band imaging surveillance cystoscopy.. 107. 2010
Urinary fistulae after partial nephrectomy.. 106. 2010
Lymph node dissection during robotic-assisted laparoscopic prostatectomy: comparison of lymph node yield and clinical outcomes when including common iliac nodes with standard template dissection.. 106. 2010
Narrow-band imaging cystoscopy to evaluate bladder tumours--individual surgeon variability.. 106. 2009
Developments in the surgical management of sporadic synchronous bilateral renal tumours.. 105. 2009
Critical analysis of complications after robotic-assisted radical cystectomy with identification of preoperative and operative risk factors.. 105. 2009
Biochemical recurrence rate in patients with positive surgical margins at radical prostatectomy with further negative resected tissue.. 104. 2009
Androgen receptor expression is associated with prostate cancer-specific survival in castrate patients with metastatic disease.. 105. 2009
Obesity is associated with a higher risk of clear-cell renal cell carcinoma than with other histologies.. 105. 2009
Incidental angiomyolipoma resected during renal surgery for an enhancing renal mass.. 104. 2009
Impact of ethnicity on surgical margins at radical prostatectomy.. 104. 2009
Magnetic resonance imaging in the prediction of biochemical recurrence of prostate cancer after radical prostatectomy.. 104. 2009
Metanephric adenoma of the kidney: clinical and radiological study of nine cases.. 103. 2009
P-cadherin as a prognostic indicator and a modulator of migratory behaviour in bladder carcinoma cells.. 102. 2008
Prostate-specific antigen flare phenomenon with docetaxel-based chemotherapy in patients with androgen-independent prostate cancer.. 102. 2008
Advanced-stage renal cell carcinoma treated by radical nephrectomy and adjacent organ or structure resection.. 103. 2008
A comparison of white-light cystoscopy and narrow-band imaging cystoscopy to detect bladder tumour recurrences.. 102. 2008
Comparison of gelatine matrix-thrombin sealants used during laparoscopic partial nephrectomy.. 102. 2008
Contemporary imaging of patients with a renal mass: does size on computed tomography equal pathological size?. 103. 2008
Subclinical haemostatic activation and current surgeon volume predict bleeding with open radical retropubic prostatectomy.. 102. 2008
Nitrofurantoin: the return of an old friend in the wake of growing resistance.. 102. 2008
Radical prostatectomy in men aged >or=70 years: effect of age on upgrading, upstaging, and the accuracy of a preoperative nomogram.. 101. 2008
Tumour growth inhibition by an imidazoquinoline is associated with c-Myc down-regulation in urothelial cell carcinoma.. 101. 2008
Patient selection determines the prostate cancer yield of dynamic contrast-enhanced magnetic resonance imaging-guided transrectal biopsies in a closed 3-Tesla scanner.. 101. 2007
Prognostic significance of altered p120 ctn expression in bladder cancer.. 101. 2007
Robotic vs open radical cystectomy: prospective comparison of perioperative outcomes and pathological measures of early oncological efficacy.. 101. 2007
Progression after docetaxel-based chemotherapy in androgen-independent prostate cancer.. 100. 2007
Prognostic significance of p27Kip1 expression in bladder cancer.. 100. 2007
Clinical outcome following post-chemotherapy retroperitoneal lymph node dissection in men with intermediate- and poor-risk nonseminomatous germ cell tumour.. 99. 2007
Magnetic resonance imaging-directed transrectal ultrasonography-guided biopsies in patients at risk of prostate cancer.. 99. 2007
The role of the prostacyclin receptor antagonist RO3244019 in treating neurogenic detrusor overactivity after spinal cord injury in rats.. 99. 2007
Renal cell carcinoma sub-typing by histopathology and fluorescence in situ hybridization on a needle-biopsy specimen.. 99. 2006
Impact of positive surgical margins in patients undergoing partial nephrectomy for renal cortical tumours.. 99. 2006
Prospective evaluation of p53 as a prognostic marker in T1 transitional cell carcinoma of the bladder.. 99. 2006
Comparison of outcomes in elective partial vs radical nephrectomy for clear cell renal cell carcinoma of 4-7 cm.. 97. 2006
Renal cell carcinoma local recurrences: impact of surgical treatment and concomitant metastasis on survival.. 97. 2006
A re-staging transurethral resection predicts early progression of superficial bladder cancer.. 97. 2006
A population-based study of renal cell carcinoma and prostate cancer in the same patients.. 97. 2006
Mini-flank supra-11th rib incision for open partial or radical nephrectomy.. 97. 2006
Managing varicoceles in children: results with microsurgical varicocelectomy.. 95. 2005
Partial nephrectomy for patients with a solitary kidney: the Memorial Sloan-Kettering experience.. 94. 2004
The impact of sildenafil citrate on sexual satisfaction profiles in men with a penile prosthesis in situ.. 93. 2004
The role of thoracotomy in managing postchemotherapy residual thoracic masses in patients with nonseminomatous germ cell tumours.. 91. 2003
Are dietary influences on the risk of prostate cancer mediated through the insulin-like growth factor system?. 87. 2001
Chemotherapy, management of bladder tumours.. 85. 2000
Apples and oranges. Re: 7.4-year update of the ongoing bicalutamide Early Prostate Cancer (EPC) trial programme. 2006
Continued gender imbalance on panels at urology meetings. 2023
Non-invasive diagnosis and monitoring of urothelial bladder cancer: are we there yet?. 124. 2019
Potential new strategies for the treatment of renal medullary carcinoma.. 120. 2017
Active surveillance for prostate cancer: is it too active?. 118. 2016
Role of prostate artery embolization in the management of refractory haematuria of prostatic origin. 2016
Urinary diversion after radical cystectomy for bladder cancer: options, patient selection, and outcomes. 2014
Novel therapeutics for the management of castration-resistant prostate cancer (CRPC). 2011
Partial nephrectomy for renal cancer (part II): the impact of renal ischaemia, patient preparation, surgical approaches, management of complications and utilization. 2010
Partial nephrectomy for renal cancer: Part I. 2010
Molecular events in germ cell tumours: linking chromosome-12 gain, acquisition of pluripotency and response to cisplatin. 2009
Retroperitoneal lymph node dissection after chemotherapy. 2009
Retroperitoneal lymph node dissection: reassessment of modified templates. 2009
A review of the pharmacokinetic and pharmacological properties of a once-yearly administered histrelin acetate implant in the treatment of prostate cancer. 2009
Therapy targeted at vascular endothelial growth factor in metastatic renal cell carcinoma: biology, clinical results and future development. 2005
Application of Artificial Intelligence to Overcome Clinical Information Overload in Urologic Cancer. 2021
Role of magnetic resonance imaging in bladder cancer: current status and emerging techniques. 2012
Cost-analysis comparison of robot-assisted laparoscopic radical cystectomy (RC) vs open RC. 2011
Neoadjuvant systemic therapy for urological malignancies. 2010
Role of targeted therapy in the treatment of advanced prostate cancer. 2010
Management of good risk germ-cell tumours. 2009
Treatment of metastatic urothelial cancer: opportunities for drug discovery and development. 2008
Signal-transduction inhibitors in renal cell carcinoma. 2007
Renal artery embolization: clinical indications and experience from over 100 cases. 2006
Satraplatin in the treatment of hormone-refractory prostate cancer. 2005
Chemotherapy and management of bladder tumours. 2000

VIVO Weill Cornell Medical College

BJU international Journal

Overview

publication venue for

Identity

ISO Abbreviation

Linking ISSN

International Standard Serial Number (ISSN)

Electronic International Standard Serial Number (EISSN)